tiprankstipranks
PHARMABEES
Nippon India Nifty Pharma ETF Units Exchange Traded Fund
Advertisement

IN:PHARMABEES ETF Technical Analysis

Compare

Summary of all the Indicators

Summary
Sell
3Bullish
6Neutral
11Bearish
Oscillators
Neutral
2Bullish
6Neutral
2Bearish
Moving Averages
Strong Sell
1Bullish
0Neutral
9Bearish
Nippon India Nifty Pharma ETF Units Exchange Traded Fund’s (PHARMABEES) Moving Averages Convergence Divergence (MACD) indicator is -0.17, suggesting Nippon India Nifty Pharma ETF Units Exchange Traded Fund is a Buy.
Nippon India Nifty Pharma ETF Units Exchange Traded Fund’s (PHARMABEES) 20-Day exponential moving average is 22.84, making it a Sell.
Nippon India Nifty Pharma ETF Units Exchange Traded Fund’s (PHARMABEES) 50-Day exponential moving average is 22.98, making it a Sell.

Nippon India Nifty Pharma ETF Units Exchange Traded Fund (PHARMABEES) Pivot Points

Apr 15, 2026, 05:36 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
21.37
21.77
22.26
22.66
23.15
23.55
24.04
Fibonacci
21.77
22.11
22.32
22.66
23.00
23.21
23.55

Nippon India Nifty Pharma ETF Units Exchange Traded Fund (PHARMABEES) Moving Averages

Apr 15, 2026, 05:36 AM
Period
Simple
Exponential
MA5
22.63Sell
22.65Sell
MA10
22.63Buy
22.70Sell
MA20
22.90Sell
22.84Sell
MA50
22.99Sell
22.98Sell
MA100
23.09Sell
23.02Sell
Nippon India Nifty Pharma ETF Units Exchange Traded Fund’s (PHARMABEES) 10-Day exponential moving average is 22.70, making it a Sell.
Nippon India Nifty Pharma ETF Units Exchange Traded Fund’s (PHARMABEES) 100-Day exponential moving average is 23.02, making it a Sell.
Nippon India Nifty Pharma ETF Units Exchange Traded Fund’s (PHARMABEES) 50-day simple moving average is 22.99, creating a Sell signal.
Nippon India Nifty Pharma ETF Units Exchange Traded Fund’s (PHARMABEES) 100-day simple moving average is 23.09, creating a Sell signal.

Nippon India Nifty Pharma ETF Units Exchange Traded Fund (PHARMABEES) Technical Analysis

Apr 15, 2026, 05:36 AM
Name
Value
Action
RSI (14)
44.61
Neutral
STOCH (9,6)
58.19
Neutral
STOCHRSI (14)
55.93
Neutral
MACD (12,26)
-0.17
Buy
ADX (14)
25.32
Neutral
Williams %R
-48.33
Buy
CCI (14)
-76.73
Neutral
ATR (14)
0.68
-
Ultimate Oscillator
58.82
Neutral
ROC
-0.88
Sell
Nippon India Nifty Pharma ETF Units Exchange Traded Fund’s (PHARMABEES) Relative Strength Index (RSI) is 44.61, creating a Neutral signal.
Nippon India Nifty Pharma ETF Units Exchange Traded Fund’s (PHARMABEES) Trend Strength Indicator (ADX) is 25.32, creating a Neutral signal.
Nippon India Nifty Pharma ETF Units Exchange Traded Fund’s (PHARMABEES) Commodity Channel Index (CCI) is -76.73, creating a Neutral signal.
Nippon India Nifty Pharma ETF Units Exchange Traded Fund’s (PHARMABEES) Price Rate of Change (ROC) is -0.88, creating a Sell signal.

FAQ

Is PHARMABEES a Buy, Hold, or Sell?
Based on PHARMABEES’s technical indicators, PHARMABEES is a Sell.
    What is PHARMABEES’s RSI (14)?
    PHARMABEES’s RSI (14) is 44.61, which suggests PHARMABEES is a Neutral.
      What is PHARMABEES’s MACD?
      PHARMABEES’s MACD is -0.17, which suggests PHARMABEES is a Buy.
        What is PHARMABEES’s 5-day moving average?
        PHARMABEES’s 5-day moving average is 22.63, which suggests PHARMABEES is a Sell.
          What is PHARMABEES’s 20-day moving average?
          PHARMABEES 20-day moving average is 22.90, which suggests PHARMABEES is a Sell.
            What is PHARMABEES’s 50-day moving average?
            PHARMABEES’s 50-day moving average is 22.99, which suggests PHARMABEES is a Sell.
              What is PHARMABEES’s 200-day moving average?
              Currently, no data Available
              What is PHARMABEES’s Williams % R (14)?
              PHARMABEES’s Williams % R (14) is -48.33, which suggests PHARMABEES is a Buy.
                What is PHARMABEES’s CCI (14)?
                PHARMABEES’s CCI (14) is -76.73, which suggests PHARMABEES is a Neutral.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis
                  Advertisement